Compare Blackrock Inc (BLK) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackrock Inc vs Intuitive Surgical, Inc. — how do they compare? Blackrock Inc trades at $1,153.61 (market cap $177.92B), while Intuitive Surgical, Inc. trades at $402.81 (market cap $141.75B). The key difference: Blackrock Inc is the larger of the two by market cap, and Blackrock Inc pays a 2% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| BLK | ISRG | |
|---|---|---|
Market Cap | $177.92B | $141.75B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $592.85 |
52-Week Low | $922.90 | $332.02 |
Enterprise Value | $179.02B | $136.53B |
Dividend Yield | 2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BlackRock (BLK) trades at $1,153.57, up 1.96% today, reflecting strong momentum. The stock shows bullish technical signals with consistent earnings beats in recent quarters, including Q2 2026 EPS of $13.91 versus $12.69 expected. Revenue grew to $24.22 billion in 2025, though net income margin dipped to 22.93%. Recent news highlights BlackRock's involvement in a $500 billion AI financing initiative with partners like Apollo and Nvidia, signaling strategic growth avenues.
The outlook remains positive with a consensus price target of $1,350, implying 17% upside. Key opportunities include robust analyst support (79% buy ratings) and dividend stability, while risks involve legal investigations into mutual fund practices and volatile cash flows, with net cash flow negative $1.29 billion in 2025. Investors should weigh solid fundamentals against regulatory and execution risks.
Intuitive Surgical (ISRG) trades at $403.95, up 2.69% on the day, reflecting strong momentum. The stock exhibits bullish technical signals with support at $398 and resistance at $403. Fundamentally, revenue grew to $10.06B in 2025 with a net income margin of 28.45%, though valuation ratios like a P/E of 46.01 suggest premium pricing. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.80 exceeding expectations. News highlights analyst upgrades and robust adoption of the da Vinci 5 system.
Outlook remains positive driven by innovation and market expansion, but high valuation and competitive pressures pose risks. The consensus price target of $518.10 implies significant upside, supported by 68% buy ratings from analysts. Key risks include reliance on U.S. procedure growth and rising competition from Medtronic and Johnson & Johnson. Long-term growth prospects appear solid if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
